Screener / SEC EDGAR /CIK 0001076930 /10-K filed Feb 23, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Technology peers:
Nasdaq Technology · Miscellaneous Electrical Machinery, Equipment & Supplies

Novanta Inc NOVT

Employees
3,000
Headquarters
Bedford, MA
CEO
Matthijs Glastra
Next results
around Feb 22, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $980.6M through the costs to a net profit of $53.8M · income statement of the 10-K

10% operating margin
Revenue to Gross profit: $435.3MRevenue to Cost of revenue: $545.3MGross profit to Operating profit: $94.0MGross profit to Operating expenses: $341.3MOperating profit to Net profit: $53.8MOperating profit to Tax & other: $40.2MOperating expenses to R&D: $95.5MOperating expenses to Sales, admin & other: $245.8M Revenue: $980.6M REVENUE $980.6M +3% Y/Y Gross profit: $435.3M · 44% margin GROSS PROFIT $435.3M 44% margin · +3% Y/Y Cost of revenue: $545.3M · 56% of revenue COST OF REVENUE $545.3M 56% of revenue Operating profit: $94.0M · 10% margin OPERATING PROFIT $94.0M 10% margin · −15% Y/Y Operating expenses: $341.3M · 35% of revenue OPERATING EXPENSES $341.3M 35% of revenue Net profit: $53.8M · 5% margin NET PROFIT $53.8M 5% margin · −16% Y/Y Tax & other: $40.2M · 4% of revenue TAX & OTHER $40.2M 4% of revenue R&D: $95.5M · 10% of revenue R&D $95.5M 10% of revenue Sales, admin & other: $245.8M · 25% of revenue SALES, ADMIN & OTHER $245.8M 25% of revenue
Gross profit $435.3M 44% margin · +3% Y/Y
Operating profit $94.0M 10% margin · −15% Y/Y
Net profit $53.8M 5% margin · −16% Y/Y
The full income statement, year by year

NOVT among Technology peers

Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.

Compare
Revenue growth: 3.3%, above 19% of 230 peers (their median 13.4%) REVENUE GROWTH 3.3% · above 19% Gross margin: 44.5%, above 24% of 210 peers (their median 61.4%) GROSS MARGIN 44.5% · above 24% Operating margin: 7.8%, above 40% of 222 peers (their median 11.5%) OPERATING MARGIN 7.8% · above 40% Net margin: 4.9%, above 31% of 228 peers (their median 10.4%) NET MARGIN 4.9% · above 31% FCF margin: 12.9%, above 31% of 225 peers (their median 20.0%) FCF MARGIN 12.9% · above 31% Return on capital: 3.0%, above 16% of 160 peers (their median 9.8%) RETURN ON CAPITAL 3.0% · above 16%
NOVT Peer median Below the median

What changed

3 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 23, 2026 against Feb 25, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

2facts worth reading about the other 9 checks found nothing to note

  • Receivables growing faster than revenue
    Receivables +22.4% ($151.0M to $184.9M) vs revenue +3.3% ($949.2M to $980.6M), +19.1 pts apart
  • Inventory growing faster than revenue
    Inventory +30.2% ($144.6M to $188.3M) vs revenue +3.3% ($949.2M to $980.6M), +26.9 pts apart
  • Cash from operations $64.1M vs net income $53.8M (FY ending Dec 31, 2025)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: Deloitte & Touche LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • No longer listed: Motion Solutions Acquisition
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

3 paragraphs in Risk Factors that were not in the 10-K filed Feb 25, 2025. Quoted as filed.

All 3 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
    On June 16, 2025, an amendment to the UK Medical Devices Regulations became applicable, and it strengthened the post-market surveillance requirements for medical devices in Great Britain. In addition, the MHRA launched a consultation from November 14, 2024 to January 5, 2025 on proposals to update the pre-market requirements for medical…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
    In addition, the market price of our common shares may be influenced by the Units. For example, the market price of our common shares could become more volatile and could be depressed by (i) investors’ anticipation of the potential resale in the market of a substantial number of our additional common shares received upon settlement of…

New risk paragraphs, against peers

Latest 10-K of each, Technology companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$860.9M$881.7M$949.2M$980.6M
Net income$74.1M$72.9M$64.1M$53.8M
Operating cash flow$90.8M$120.1M$158.5M$64.1M
Free cash flow$71.1M$100.1M$141.3M$48.4M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$980.6M ▲ 3.3% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

4 filings in the last 30 days · SEC EDGAR

All filings

About the company

Novanta Inc, Bedford, MA · from the 10-K filed Feb 23, 2026

Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables us to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications.

Headquarters
Bedford, MA
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Nov 9, 2026
Incorporated in
New Brunswick, Canada

Employees, at the top of the page: "As of December 31, 2025, we employed approximately 3,000 people, of which approximately 36% were in the United States, 55% in Europe, and 9% in Asia" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 23, 2026 (open at SEC), compared with the 10-K filed Feb 25, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NOVT/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.